Considering risk.

G Reichman

PubMed · 10623346

Considering risk.

Abstract

Medical device manufacturers have to go to a lot of effort before they can bring a new product to market. Even when the product is on the market there are many things to consider to keep it there. These efforts are deemed worth making, because they believe that there will be a "return on investment." In many cases this expectation proves to be right, sometimes it does not. They must be prepared to take some risk. This article discusses the regulated environment in which research into (new) medical devices takes place and the management of regulatory risk.

Explore related subjects

Equipment Design Equipment Failure Equipment Safety Equipment and Supplies Humans Industry Manufactured Materials Netherlands Risk Management Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

G Reichman. Considering risk.. https://pubmed.ncbi.nlm.nih.gov/10623346/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2002

Large-aperture automatic focimeter for the measurement of optical power and other optical characteristics of ophthalmic lenses.

We propose an optical apparatus enabling the measurement of spherical power, cylindrical power, and optical center coordinates of ophthalmic lenses. The main advantage of this new focimeter is to provide a full bidimensional mapping of the characteristics of ophthalmic glasses. This is made possible thanks to the use of a large-area and high-resolution position-sensitive detector. We describe the measurement principle and present some typical mappings, particularly for progressive lenses. We then discuss the advantages in terms of speed and versatility of such a focimeter for the measurement of complex lens mappings.

Equipment Design↗

PubMed2002

The multipurpose syringe: finger splints.

Explore the source record for details and available documents.

Equipment Design↗

PubMed2002

Steric-hyperlayer sedimentation field flow fractionation and flow cytometry analysis applied to the study of Saccharomyces cerevisiae.

Sedimentation field flow fractionation separation associated with flow cytometry has been used for the characterization of several commercial Saccharomyces cerevisiae yeasts used for wine production. A new type of channel 80 microm thick and new operating conditions, such as sample introduction when field and flow are established and a channel inlet connected to the accumulation wall, were used. Good repeatability (5% RSD) and reduced analysis time (2-10 min) were obtained. The avoidance of the stop-flow relaxation process in conjunction with the use of a channel of reduced thickness has demonstrated that an effective "steric-hyperlayer" mode driving to a major focusing effect of the species in the channel thickness is involved in the elution of the yeast cells. Flow cytometry analyses were performed, and the forward scattering and side scattering yeast characteristics correlation maps were obtained. Field flow fractionation and flow cytometry information obtained indicated that the fractogram profiles of the yeast cell depended not only on the size, but also on the shape and density.

Equipment Design↗